AI-generated summary
The authors randomized 50 women with melasma to six sessions of low fluence 1064-nm Q-switched Nd:YAG laser or topical silymarin cream for three months. Both groups showed significant reductions in melasma severity with no recorded side effects, and the groups did not differ significantly. The study is small and short-term.
- Participants
- 50
- Who or what was studied
- Women with melasma
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- Small, short-term randomized trial of 50 patients evaluated only over the short term.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Fluence, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.